Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Revance Therapeutics Operating Income 2012-2023 | RVNC

Revance Therapeutics operating income from 2012 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  
Revance Therapeutics Annual Operating Income
(Millions of US $)
2023 $-317
2022 $-342
2021 $-275
2020 $-273
2019 $-164
2018 $-143
2017 $-120
2016 $-88
2015 $-72
2014 $-52
2013 $-38
2012 $-43
2011 $-28
Revance Therapeutics Quarterly Operating Income
(Millions of US $)
2023-12-31 $-54
2023-09-30 $-139
2023-06-30 $-65
2023-03-31 $-58
2022-12-31 $-144
2022-09-30 $-77
2022-06-30 $-58
2022-03-31 $-62
2021-12-31 $-62
2021-09-30 $-73
2021-06-30 $-70
2021-03-31 $-70
2020-12-31 $-78
2020-09-30 $-77
2020-06-30 $-57
2020-03-31 $-61
2019-12-31 $-46
2019-09-30 $-43
2019-06-30 $-39
2019-03-31 $-37
2018-12-31 $-38
2018-09-30 $-34
2018-06-30 $-35
2018-03-31 $-36
2017-12-31 $-36
2017-09-30 $-31
2017-06-30 $-27
2017-03-31 $-27
2016-12-31 $-27
2016-09-30 $-18
2016-06-30 $-24
2016-03-31 $-20
2015-12-31 $-22
2015-09-30 $-19
2015-06-30 $-17
2015-03-31 $-15
2014-12-31 $-14
2014-09-30 $-14
2014-06-30 $-13
2014-03-31 $-11
2013-12-31 $-9
2013-09-30 $-8
2013-06-30 $-11
2013-03-31 $-10
2012-12-31
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.363B $0.234B
Revance is a Silicon Valley-based biotechnology company. The company is developing a portfolio of products for aesthetic medicine and underserved therapeutic specialties, including dermatology and neurology. Revance's science is based upon a proprietary TransMTS? peptide technology, which when combined with active drug molecules, may help address current unmet needs. Revance's initial focus is on developing daxibotulinumtoxinA, the company's highly purified botulinum toxin, for a broad spectrum of aesthetic and therapeutic indications, including facial wrinkles and muscle movement disorders. The company's lead drug candidate, DaxibotulinumtoxinA for Injection (RT002), is currently in development for the treatment of glabellar lines and cervical dystonia and has the potential to be the first long-acting neurotoxin. The company holds worldwide rights for all indications of RT002 injectable and RT001 topical and the pharmaceutical uses of the TransMTS technology platform.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $167.051B 16.72
Vertex Pharmaceuticals (VRTX) United States $110.599B 28.46
Regeneron Pharmaceuticals (REGN) United States $108.493B 26.53
GSK (GSK) United Kingdom $94.628B 11.30
Bristol Myers Squibb (BMY) United States $90.632B 42.58
CSL (CSLLY) Australia $89.769B 0.00
Gilead Sciences (GILD) United States $84.282B 16.79
Moderna (MRNA) United States $49.177B 0.00
Biogen (BIIB) United States $33.033B 15.12
BioNTech SE (BNTX) Germany $21.937B 184.56
Argenex SE (ARGX) Netherlands $21.158B 0.00
Genmab (GMAB) Denmark $19.526B 22.89
Alnylam Pharmaceuticals (ALNY) United States $18.707B 0.00
Illumina (ILMN) United States $18.412B 131.34
BeiGene (BGNE) Cayman Islands $15.384B 0.00
BioMarin Pharmaceutical (BMRN) United States $15.124B 59.00
Bio-Techne Corp (TECH) United States $13.261B 50.09
Incyte (INCY) United States $12.810B 19.81
Sarepta Therapeutics (SRPT) United States $12.540B 1105.50
QIAGEN (QGEN) Netherlands $10.358B 22.13
Exact Sciences (EXAS) United States $9.965B 0.00
Repligen (RGEN) United States $9.637B 125.90
Roivant Sciences (ROIV) United Kingdom $9.130B 0.00
Legend Biotech (LEGN) United States $8.073B 0.00
Viking Therapeutics (VKTX) United States $7.994B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.983B 26.11
Vaxcyte (PCVX) United States $7.325B 0.00
Ascendis Pharma (ASND) Denmark $7.268B 0.00
Intra-Cellular Therapies (ITCI) United States $6.937B 0.00
Blueprint Medicines (BPMC) United States $6.454B 0.00
Exelixis (EXEL) United States $6.364B 32.80
Cytokinetics (CYTK) United States $6.224B 0.00
ImmunityBio (IBRX) United States $5.809B 0.00
Halozyme Therapeutics (HALO) United States $5.577B 15.48
Apellis Pharmaceuticals (APLS) United States $5.000B 0.00
Zealand Pharma (ZLDPF) Denmark $4.778B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.731B 0.00
Krystal Biotech (KRYS) United States $4.554B 0.00
Immunovant (IMVT) United States $4.429B 0.00
Nuvalent (NUVL) United States $4.358B 0.00
Alkermes (ALKS) Ireland $4.144B 16.22
Insmed (INSM) United States $3.782B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.729B 0.00
Axsome Therapeutics (AXSM) United States $3.673B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.406B 0.00
Biohaven (BHVN) United States $3.288B 0.00
SpringWorks Therapeutics (SWTX) United States $3.182B 0.00
IDEAYA Biosciences (IDYA) United States $3.164B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.063B 0.00
Guardant Health (GH) United States $3.026B 0.00
Iovance Biotherapeutics (IOVA) United States $3.000B 0.00
Denali Therapeutics (DNLI) United States $2.817B 0.00
Twist Bioscience (TWST) United States $2.802B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.782B 0.00
MorphoSys AG (MOR) Germany $2.770B 0.00
Avidity Biosciences (RNA) United States $2.765B 0.00
Amicus Therapeutics (FOLD) United States $2.764B 0.00
Arcellx (ACLX) United States $2.708B 0.00
Certara (CERT) United States $2.641B 60.81
Merus (MRUS) Netherlands $2.627B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.605B 0.00
Celldex Therapeutics (CLDX) United States $2.601B 0.00
Fortrea Holdings (FTRE) United States $2.578B 31.69
Janux Therapeutics (JANX) United States $2.484B 0.00
Intellia Therapeutics (NTLA) United States $2.482B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.462B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.455B 0.00
Apogee Therapeutics (APGE) United States $2.428B 0.00
Vericel (VCEL) United States $2.359B 0.00
Myriad Genetics (MYGN) United States $2.295B 0.00
Vera Therapeutics (VERA) United States $2.225B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.200B 0.00
Geron (GERN) United States $2.183B 0.00
Kymera Therapeutics (KYMR) United States $2.153B 0.00
Arvinas (ARVN) United States $2.146B 0.00
Zai Lab (ZLAB) China $2.138B 0.00
Rocket Pharmaceuticals (RCKT) United States $2.122B 0.00
ADMA Biologics Inc (ADMA) United States $2.091B 83.27
NeoGenomics (NEO) United States $1.967B 0.00
Beam Therapeutics (BEAM) United States $1.960B 0.00
Keros Therapeutics (KROS) United States $1.905B 0.00
Sana Biotechnology (SANA) United States $1.905B 0.00
Novavax (NVAX) United States $1.893B 0.00
Galapagos (GLPG) Belgium $1.887B 0.00
Bavarian Nordic (BVNRY) Denmark $1.884B 8.20
Ginkgo Bioworks Holdings (DNA) United States $1.857B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.841B 0.00
CG Oncology (CGON) United States $1.821B 0.00
Inhibrx (INBX) United States $1.789B 0.00
Protagonist Therapeutics (PTGX) United States $1.737B 12.14
Harmony Biosciences Holdings (HRMY) United States $1.696B 12.93
Structure Therapeutics (GPCR) United States $1.664B 0.00
Edgewise Therapeutics (EWTX) United States $1.629B 0.00
Kura Oncology (KURA) United States $1.593B 0.00
Spyre Therapeutics (SYRE) United States $1.583B 0.00
Arcus Biosciences (RCUS) United States $1.556B 0.00
Ligand Pharmaceuticals (LGND) United States $1.535B 25.08
Neumora Therapeutics (NMRA) United States $1.528B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.452B 0.00
Dynavax Technologies (DVAX) United States $1.440B 183.33
Tarsus Pharmaceuticals (TARS) United States $1.435B 0.00
Morphic Holding (MORF) United States $1.421B 0.00
Akero Therapeutics (AKRO) United States $1.404B 0.00
ANI Pharmaceuticals (ANIP) United States $1.392B 17.19
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.382B 0.00
Vir Biotechnology (VIR) United States $1.371B 0.00
Gyre Therapeutics (GYRE) United States $1.348B 0.00
MannKind (MNKD) United States $1.225B 150.00
Belite Bio (BLTE) United States $1.224B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.169B 0.00
MiMedx (MDXG) United States $1.163B 49.25
Cullinan Therapeutics (CGEM) United States $1.136B 0.00
AbCellera Biologics (ABCL) Canada $1.123B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.122B 0.00
Scholar Rock Holding (SRRK) United States $1.117B 0.00
Prothena (PRTA) Ireland $1.112B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.045B 0.00
Immatics (IMTX) Germany $0.982B 0.00
Tyra Biosciences (TYRA) United States $0.976B 0.00
Arcutis Biotherapeutics (ARQT) United States $0.939B 0.00
Viridian Therapeutics (VRDN) United States $0.936B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.935B 0.00
Liquidia Technologies (LQDA) United States $0.914B 0.00
89BIO (ETNB) United States $0.894B 0.00
Immunome (IMNM) United States $0.882B 0.00
Abivax SA (ABVX) France $0.872B 0.00
Pliant Therapeutics (PLRX) United States $0.853B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.829B 0.00
Cytek Biosciences (CTKB) United States $0.827B 0.00
Mesoblast (MESO) Australia $0.822B 0.00
Dianthus Therapeutics (DNTH) United States $0.820B 0.00
Tango Therapeutics (TNGX) United States $0.812B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.801B 0.00
Prime Medicine (PRME) United States $0.799B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.791B 0.00
ALX Oncology Holdings (ALXO) United States $0.790B 0.00
Disc Medicine (IRON) United States $0.786B 0.00
Praxis Precision Medicines (PRAX) United States $0.785B 0.00
REGENXBIO (RGNX) United States $0.778B 0.00
CARGO Therapeutics (CRGX) United States $0.776B 0.00
Humacyte (HUMA) United States $0.765B 0.00
PureTech Health (PRTC) United States $0.744B 0.00
Nurix Therapeutics (NRIX) United States $0.735B 0.00
Nuvation Bio (NUVB) United States $0.720B 0.00
WAVE Life Sciences (WVE) Singapore $0.715B 0.00
Cogent Biosciences (COGT) United States $0.703B 0.00
CureVac (CVAC) Germany $0.694B 0.00
AnaptysBio (ANAB) United States $0.690B 0.00
GH Research (GHRS) Ireland $0.677B 0.00
Kyverna Therapeutics (KYTX) United States $0.668B 0.00
Stoke Therapeutics (STOK) United States $0.667B 0.00
Castle Biosciences (CSTL) United States $0.660B 0.00
HilleVax (HLVX) United States $0.653B 0.00
Pharming Group (PHAR) Netherlands $0.649B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.648B 0.00
Mineralys Therapeutics (MLYS) United States $0.648B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Zymeworks (ZYME) United States $0.636B 0.00
Pharming Group (PHGUF) Netherlands $0.622B 0.00
EnGene Holdings (ENGN) United States $0.621B 0.00
ArriVent BioPharma (AVBP) United States $0.618B 0.00
Oric Pharmaceuticals (ORIC) United States $0.613B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.608B 0.00
Northwest Biotherapeutics (NWBO) United States $0.605B 0.00
ITeos Therapeutics (ITOS) United States $0.604B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.597B 0.00
Avid Bioservices (CDMO) United States $0.584B 0.00
Adaptive Biotechnologies (ADPT) United States $0.584B 0.00
Olema Pharmaceuticals (OLMA) United States $0.569B 0.00
Aerovate Therapeutics (AVTE) United States $0.555B 0.00
Absci (ABSI) United States $0.546B 0.00
IGM Biosciences (IGMS) United States $0.541B 0.00
Arbutus Biopharma (ABUS) United States $0.540B 0.00
Applied Therapeutics (APLT) United States $0.530B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.527B 0.00
Third Harmonic Bio (THRD) United States $0.526B 0.00
Cabaletta Bio (CABA) United States $0.526B 0.00
Astria Therapeutics (ATXS) United States $0.521B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.519B 0.00
Celcuity (CELC) United States $0.514B 0.00
Alector (ALEC) United States $0.514B 0.00
Travere Therapeutics (TVTX) United States $0.510B 0.00
Allogene Therapeutics (ALLO) United States $0.506B 0.00
Oculis Holding AG (OCS) Switzerland $0.493B 0.00
Fulcrum Therapeutics (FULC) United States $0.492B 0.00
Fate Therapeutics (FATE) United States $0.480B 0.00
Adlai Nortye (ANL) Cayman Islands $0.480B 0.00
Entrada Therapeutics (TRDA) United States $0.479B 22.52
MaxCyte (MXCT) United States $0.475B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.473B 0.00
ACELYRIN, INC (SLRN) United States $0.468B 0.00
Editas Medicine (EDIT) United States $0.467B 0.00
Voyager Therapeutics (VYGR) United States $0.461B 0.00
PepGen (PEPG) United States $0.453B 0.00
Annexon (ANNX) United States $0.445B 0.00
Biomea Fusion (BMEA) United States $0.445B 0.00
Ocugen (OCGN) United States $0.437B 0.00
TScan Therapeutics (TCRX) United States $0.430B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.415B 0.00
C4 Therapeutics (CCCC) United States $0.413B 0.00
Replimune (REPL) United States $0.412B 0.00
Neurogene (NGNE) United States $0.410B 0.00
Shattuck Labs (STTK) United States $0.403B 0.00
Terns Pharmaceuticals (TERN) United States $0.387B 0.00
Alto Neuroscience (ANRO) United States $0.381B 0.00
Anika Therapeutics (ANIK) United States $0.379B 319.88
Solid Biosciences (SLDB) United States $0.377B 0.00
Amarin (AMRN) Ireland $0.374B 0.00
Aura Biosciences (AURA) United States $0.373B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.372B 0.00
FibroBiologics (FBLG) United States $0.369B 0.00
Anavex Life Sciences (AVXL) United States $0.365B 0.00
Nautilus Biotechnology (NAUT) United States $0.358B 0.00
AC Immune (ACIU) Switzerland $0.354B 0.00
Tenaya Therapeutics (TNYA) United States $0.345B 0.00
Precigen (PGEN) United States $0.341B 0.00
MeiraGTx Holdings (MGTX) United States $0.336B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.334B 0.00
Atea Pharmaceuticals (AVIR) United States $0.334B 0.00
Verastem (VSTM) United States $0.333B 0.00
Caribou Biosciences (CRBU) United States $0.329B 0.00
Kamada (KMDA) Israel $0.325B 24.61
Nkarta (NKTX) United States $0.324B 0.00
Erasca (ERAS) United States $0.322B 0.00
Mersana Therapeutics (MRSN) United States $0.319B 0.00
Jasper Therapeutics (JSPR) United States $0.315B 0.00
Candel Therapeutics (CADL) United States $0.314B 0.00
Urogen Pharma (URGN) United States $0.304B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.299B 0.00
XOMA (XOMA) United States $0.298B 0.00
Inovio Pharmaceuticals (INO) United States $0.296B 0.00
23andMe Holding (ME) United States $0.295B 0.00
Ventyx Biosciences (VTYX) United States $0.294B 0.00
CorMedix Inc (CRMD) United States $0.293B 0.00
Rani Therapeutics Holdings (RANI) United States $0.291B 0.00
Invivyd (IVVD) United States $0.290B 0.00
Inozyme Pharma (INZY) United States $0.286B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.284B 0.00
Poseida Therapeutics (PSTX) United States $0.283B 0.00
Contineum Therapeutics (CTNM) United States $0.282B 0.00
ChromaDex (CDXC) United States $0.276B 0.00
Sutro Biopharma (STRO) United States $0.271B 0.00
XBiotech (XBIT) United States $0.268B 0.00
Emergent Biosolutions (EBS) United States $0.266B 0.00
Prima BioMed (IMMP) Australia $0.258B 0.00
Codexis (CDXS) United States $0.258B 0.00
Design Therapeutics (DSGN) United States $0.254B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.253B 0.00
2seventy Bio (TSVT) United States $0.243B 0.00
G1 Therapeutics (GTHX) United States $0.243B 0.00
Coherus BioSciences (CHRS) United States $0.239B 0.00
UniQure (QURE) Netherlands $0.238B 0.00
Puma Biotechnology (PBYI) United States $0.238B 14.97
Ovid Therapeutics (OVID) United States $0.229B 0.00
Agenus (AGEN) United States $0.225B 0.00
Zura Bio (ZURA) United States $0.222B 0.00
Compass Therapeutics (CMPX) United States $0.222B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.222B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.220B 0.00
Werewolf Therapeutics (HOWL) United States $0.214B 0.00
Innate Pharma S.A (IPHA) France $0.213B 0.00
Opthea (OPT) Australia $0.211B 0.00
INmune Bio (INMB) United States $0.208B 0.00
Boundless Bio (BOLD) $0.207B 0.00
Trevi Therapeutics (TRVI) United States $0.206B 0.00
Kodiak Sciences (KOD) United States $0.202B 0.00
Elevation Oncology (ELEV) United States $0.195B 0.00
Inventiva S.A (IVA) France $0.192B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.186B 0.00
Lifecore Biomedical (LFCR) United States $0.186B 0.00
Adverum Biotechnologies (ADVM) United States $0.185B 0.00
GENFIT S.A (GNFT) France $0.184B 0.00
Compugen (CGEN) Israel $0.181B 0.00
Greenwich LifeSciences (GLSI) United States $0.176B 0.00
Alimera Sciences (ALIM) United States $0.172B 0.00
Adocia (ADOCY) France $0.170B 0.00
Cellectis S.A (CLLS) France $0.169B 0.00
Gossamer Bio (GOSS) United States $0.166B 0.00
X4 Pharmaceuticals (XFOR) United States $0.165B 0.00
ScPharmaceuticals (SCPH) United States $0.162B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.161B 0.00
Cardiff Oncology (CRDF) United States $0.160B 0.00
Repare Therapeutics (RPTX) Canada $0.157B 0.00
CervoMed (CRVO) United States $0.152B 0.00
CytomX Therapeutics (CTMX) United States $0.151B 9.70
BioStem Technologies (BSEM) $0.151B 0.00
Skye Bioscience (SKYE) United States $0.150B 0.00
I-Mab (IMAB) China $0.150B 0.00
Renovaro (RENB) United States $0.149B 0.00
Syros Pharmaceuticals (SYRS) United States $0.145B 0.00
Scilex Holding (SCLX) United States $0.145B 0.00
TELA Bio (TELA) United States $0.143B 0.00
Akoya Biosciences (AKYA) United States $0.143B 0.00
Seer (SEER) United States $0.140B 0.00
Sagimet Biosciences (SGMT) United States $0.140B 0.00
Rapt Therapeutics (RAPT) United States $0.140B 0.00
Vigil Neuroscience (VIGL) United States $0.138B 0.00
Seres Therapeutics (MCRB) United States $0.136B 0.00
Cartesian Therapeutics (RNAC) United States $0.132B 0.00
Omega Therapeutics (OMGA) United States $0.130B 0.00
PDS Biotechnology (PDSB) United States $0.130B 0.00
Molecular Partners AG (MOLN) Switzerland $0.129B 0.00
ATyr Pharma (LIFE) United States $0.126B 0.00
BioAtla (BCAB) United States $0.126B 0.00
Nuvectis Pharma (NVCT) United States $0.124B 0.00
VistaGen Therapeutics (VTGN) United States $0.122B 0.00
Coya Therapeutics (COYA) United States $0.121B 0.00
China Health Industries Holdings (CHHE) China $0.118B 0.00
Sangamo Therapeutics (SGMO) United States $0.118B 0.00
Bluebird Bio (BLUE) United States $0.117B 0.00
Adagene (ADAG) China $0.117B 0.00
Immunic (IMUX) United States $0.115B 0.00
Abeona Therapeutics (ABEO) United States $0.115B 0.00
Vor Biopharma (VOR) $0.115B 0.00
DiaMedica Therapeutics (DMAC) United States $0.115B 0.00
DBV Technologies S.A (DBVT) France $0.114B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.111B 0.00
Adicet Bio (ACET) United States $0.109B 0.00
Rezolute (RZLT) United States $0.108B 0.00
Connect Biopharma Holdings (CNTB) United States $0.107B 0.00
Elicio Therapeutics (ELTX) United States $0.105B 0.00
Allakos (ALLK) United States $0.105B 0.00
BeyondSpring (BYSI) United States $0.104B 0.00
BioHarvest Sciences (CNVCF) Canada $0.101B 0.00
Genelux (GNLX) United States $0.097B 0.00
Oncobiologics (OTLK) United States $0.096B 0.00
Clearside Biomedical (CLSD) United States $0.096B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.095B 0.00
IO Biotech (IOBT) Denmark $0.095B 0.00
Annovis Bio (ANVS) United States $0.093B 0.00
Eton Pharmaceuticals (ETON) United States $0.093B 90.75
Q32 Bio (QTTB) United States $0.093B 0.00
Curis (CRIS) United States $0.092B 0.00
YS Biopharma (YS) China $0.092B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.092B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.090B 0.00
Oncolytics Biotech (ONCY) Canada $0.090B 0.00
Spero Therapeutics (SPRO) United States $0.086B 3.20
Athira Pharma (ATHA) United States $0.084B 0.00
InflaRx (IFRX) Germany $0.084B 0.00
Gritstone Bio (GRTS) United States $0.083B 0.00
Passage Bio (PASG) United States $0.082B 0.00
HOOKIPA Pharma (HOOK) United States $0.082B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.082B 0.00
Elutia (ELUT) United States $0.081B 0.00
Eupraxia Pharmaceuticals (EPRX) $0.080B 0.00
Precision BioSciences (DTIL) United States $0.080B 0.00
BioXcel Therapeutics (BTAI) United States $0.080B 0.00
Affimed (AFMD) Germany $0.080B 0.00
Alpha Teknova (TKNO) United States $0.080B 0.00
Cognition Therapeutics (CGTX) United States $0.079B 0.00
Galena Biopharma (SLS) United States $0.079B 0.00
VTv Therapeutics (VTVT) United States $0.078B 0.00
Instil Bio (TIL) United States $0.077B 0.00
Rallybio (RLYB) United States $0.076B 0.00
Cue Biopharma (CUE) United States $0.075B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.075B 0.00
Bionano Genomics (BNGO) United States $0.074B 0.00
Atara Biotherapeutics (ATRA) United States $0.073B 0.00
MediciNova (MNOV) United States $0.073B 0.00
Entera Bio (ENTX) Israel $0.072B 0.00
Celularity (CELU) United States $0.071B 0.00
Leap Therapeutics (LPTX) United States $0.070B 0.00
Landos Biopharma (LABP) United States $0.070B 0.00
AN2 Therapeutics (ANTX) United States $0.069B 0.00
Lantern Pharma (LTRN) United States $0.067B 0.00
Turnstone Biologics (TSBX) United States $0.066B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.066B 0.00
Aileron Therapeutics (ALRN) United States $0.066B 0.00
Ikena Oncology (IKNA) United States $0.064B 0.00
Intensity Therapeutics (INTS) United States $0.061B 0.00
Kronos Bio (KRON) United States $0.060B 0.00
Cidara Therapeutics (CDTX) United States $0.060B 0.00
CalciMedica (CALC) United States $0.060B 0.00
Genenta Science S.p.A (GNTA) Italy $0.059B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.058B 0.00
Immix Biopharma (IMMX) United States $0.058B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.058B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.058B 0.00
AVROBIO (AVRO) United States $0.058B 0.00
Kezar Life Sciences (KZR) United States $0.057B 0.00
LENZ Therapeutics (LENZ) United States $0.057B 0.00
Enzo Biochem (ENZ) United States $0.056B 0.00
Checkpoint Therapeutics (CKPT) United States $0.056B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.055B 0.00
Equillium (EQ) United States $0.054B 0.00
Ocean Biomedical (OCEA) United States $0.054B 0.00
Aligos Therapeutics (ALGS) United States $0.052B 0.00
Bolt Biotherapeutics (BOLT) United States $0.050B 0.00
Clene (CLNN) United States $0.049B 0.00
ARCA Biopharma (ABIO) United States $0.048B 0.00
Immuneering (IMRX) United States $0.047B 0.00
Aadi Bioscience (AADI) United States $0.046B 0.00
IN8bio (INAB) United States $0.046B 0.00
NextCure (NXTC) United States $0.044B 0.00
Ocuphire Pharma (OCUP) United States $0.044B 0.00
Dyadic (DYAI) United States $0.044B 0.00
OKYO Pharma (OKYO) $0.044B 0.00
HCW Biologics (HCWB) United States $0.044B 0.00
Eyenovia (EYEN) United States $0.042B 0.00
Carmell (CTCX) United States $0.042B 0.00
Beyond Air (XAIR) United States $0.041B 0.00
Cyclo Therapeutics (CYTH) United States $0.040B 0.00
Xilio Therapeutics (XLO) United States $0.040B 0.00
Lexaria Bioscience (LEXX) Canada $0.040B 0.00
Cara Therapeutics (CARA) United States $0.040B 0.00
Quince Therapeutics (QNCX) United States $0.039B 0.00
MiNK Therapeutics (INKT) United States $0.039B 0.00
Estrella Immunopharma (ESLA) United States $0.038B 0.00
Sensei Biotherapeutics (SNSE) United States $0.038B 0.00
SAB Biotherapeutics (SABS) United States $0.037B 0.00
Promis Neurosciences (PMN) Canada $0.037B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.037B 0.00
Pluri (PLUR) Israel $0.035B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.034B 0.00
Spruce Biosciences (SPRB) United States $0.034B 0.00
Fortress Biotech (FBIO) United States $0.034B 0.00
BRIACELL THERAP (BCTX) Canada $0.034B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.033B 0.00
Aprea Therapeutics (APRE) United States $0.032B 0.00
Apollomics (APLM) United States $0.032B 0.00
Dare Bioscience (DARE) United States $0.032B 0.00
Femasys (FEMY) United States $0.031B 0.00
Theratechnologies (THTX) Canada $0.030B 0.00
Evogene (EVGN) Israel $0.028B 0.00
Biora Therapeutics (BIOR) United States $0.026B 0.00
UNITY Biotechnology (UBX) United States $0.026B 0.00
NKGen Biotech (NKGN) United States $0.026B 0.00
Forte Biosciences (FBRX) United States $0.025B 0.00
Lisata Therapeutics (LSTA) United States $0.025B 0.00
RenovoRx (RNXT) United States $0.024B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.023B 0.00
Benitec Biopharma (BNTC) United States $0.022B 0.00
BioAffinity Technologies (BIAF) United States $0.022B 0.00
Orgenesis (ORGS) United States $0.021B 0.00
Lumos Pharma (LUMO) United States $0.021B 0.00
Synlogic (SYBX) United States $0.020B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.020B 0.00
Evaxion Biotech (EVAX) Denmark $0.020B 0.00
Aptose Biosciences (APTO) Canada $0.020B 0.00
KALA BIO (KALA) United States $0.019B 0.00
Cocrystal Pharma (COCP) United States $0.019B 0.00
Aytu BioPharma (AYTU) United States $0.018B 0.00
Galecto (GLTO) Denmark $0.018B 0.00
VBI Vaccines (VBIV) United States $0.018B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.018B 0.00
Senti Biosciences (SNTI) United States $0.017B 0.00
Vincerx Pharma (VINC) United States $0.016B 0.00
Talis Biomedical (TLIS) United States $0.016B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.015B 0.00
Semper Paratus Acquisition (TVGN) United States $0.015B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.014B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
Purple Biotech (PPBT) Israel $0.013B 0.00
Eterna Therapeutics (ERNA) United States $0.013B 0.00
Imunon (IMNN) United States $0.013B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.012B 0.00
ABVC BioPharma (ABVC) United States $0.011B 0.00
Monopar Therapeutics (MNPR) United States $0.011B 0.00
Moleculin Biotech (MBRX) United States $0.011B 0.00
Elevai Labs (ELAB) United States $0.011B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.011B 0.00
Genetic Technologies (GENE) Australia $0.011B 0.00
BioCardia (BCDA) United States $0.011B 0.00
NuCana (NCNA) United Kingdom $0.010B 0.00
AEterna Zentaris (AEZS) Canada $0.010B 0.00
Organovo Holdings (ONVO) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
Chemomab Therapeutics (CMMB) Israel $0.010B 0.00
Galera Therapeutics (GRTX) United States $0.010B 0.00
Biorestorative Therapies (BRTX) United States $0.009B 0.00
AquaBounty Technologies (AQB) United States $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Trevena (TRVN) United States $0.008B 0.00
Bionomics (BNOX) Australia $0.008B 0.00
Psyence Biomedical (PBM) United States $0.008B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.007B 0.00
Virios Therapeutics (VIRI) United States $0.007B 0.00
Telesis Bio (TBIO) United States $0.007B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.007B 0.00
Cadrenal Therapeutics (CVKD) United States $0.007B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Vaccinex (VCNX) United States $0.007B 0.00
Biofrontera (BFRI) United States $0.007B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.007B 0.00
First Wave BioPharma (FWBI) United States $0.006B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Enveric Biosciences (ENVB) United States $0.006B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.006B 0.00
Kineta (KA) United States $0.006B 0.00
Palisade Bio (PALI) United States $0.006B 0.00
Adial Pharmaceuticals (ADIL) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.006B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.006B 0.00
Atrinsic (PTIX) United States $0.006B 0.00
ThermoGenesis Holdings (THMO) United States $0.005B 0.00
GENPREX (GNPX) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
Kintara Therapeutics (KTRA) United States $0.005B 0.00
Cingulate (CING) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Novogen (KZIA) Australia $0.005B 0.00
TFF Pharmaceuticals (TFFP) United States $0.005B 0.00
NexImmune (NEXI) United States $0.005B 0.00
Portage Biotech (PRTG) $0.005B 0.00
TRACON Pharmaceuticals (TCON) United States $0.004B 0.57
GT Biopharma (GTBP) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Exicure (XCUR) United States $0.004B 0.29
Ensysce Biosciences (ENSC) United States $0.004B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.004B 0.00
Alzamend Neuro (ALZN) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Seelos Therapeutics (SEEL) United States $0.004B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.004B 0.00
GeoVax Labs (GOVX) United States $0.004B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.004B 0.00
Longeveron (LGVN) United States $0.003B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
ARAVIVE, INC (ARAV) United States $0.003B 0.00
Mustang Bio (MBIO) United States $0.003B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.003B 0.00
Onconetix (ONCO) United States $0.002B 0.00
Notable Labs (NTBL) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
CNS Pharmaceuticals (CNSP) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Allarity Therapeutics (ALLR) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
GRI Bio (GRI) United States $0.002B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.001B 0.00
Sunshine Biopharma (SBFM) United States $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
Aptevo Therapeutics (APVO) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00